The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of pre-lymphodepletion (pre LD) and day 30 (M1) immune cell counts on outcomes of CAR T therapy in patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL).
 
Suheil Albert Atallah-Yunes
No Relationships to Disclose
 
Matthew Rees
No Relationships to Disclose
 
Ahmed Alnughmush
No Relationships to Disclose
 
Yucai Wang
Employment - Merck (I)
Stock and Other Ownership Interests - Merck (I)
Honoraria - Kite, a Gilead company (Inst)
Consulting or Advisory Role - Abbvie; AstraZeneca (Inst); BeiGene (Inst); Genmab (Inst); Incyte (Inst); Innocare (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Lilly (Inst); Loxo (Inst); TG Therapeutics (Inst)
Research Funding - Abbvie (Inst); BeiGene (Inst); Genentech (Inst); Genmab (Inst); Incyte (Inst); InnoCare (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); MorphoSys (Inst); Novartis (Inst)
 
Jonas Paludo
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst)
Research Funding - Biofourmis (Inst); Karyopharm Therapeutics (Inst)
 
Arushi Khurana
No Relationships to Disclose
 
Jose Villasboas
Consulting or Advisory Role - Curio Science (Inst); Kite/Gilead (Inst); Regeneron (Inst); TG Therapeutics (Inst)
Research Funding - Aptose Biosciences (Inst); Celgene/Bristol-Myers Squibb (Inst); Enterome (Inst); Epizyme (Inst); Genentech/Roche (Inst); Regeneron (Inst)
 
Andre De Menezes Silva Corraes
No Relationships to Disclose
 
Nabila Bennani
Consulting or Advisory Role - Acrotech Biopharma (Inst); Affimed Therapeutics (Inst); Astellas Pharma (Inst)
Research Funding - Vyriad (Inst)
 
Paul Hampel
Consulting or Advisory Role - Abbvie (Inst)
Research Funding - AstraZeneca (Inst); BeiGene (Inst)
 
Urshila Durani
No Relationships to Disclose
 
Luis Porrata
No Relationships to Disclose
 
Stephen Ansell
Honoraria - Answers in CME; Medscape; Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst); Step Pharma (Inst); Takeda (Inst)
 
Patrick Johnston
No Relationships to Disclose
 
Yi Lin
Consulting or Advisory Role - Adicet Bio (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences (Inst); Chimeric Therapeutics (Inst); Fosun Kite (Inst); Genentech (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Nektar (Inst); NexImmune (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tessera (Inst); Vineti (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)